Company News
MBX Biosciences Falls 8.3% on CEO Change
MBX Biosciences shares dropped 8.3% in after‑hours trading following announcement of leadership changes.
Steve Hoerter, current Executive Chairman, was appointed Chairman and CEO, replacing Kent Hawry
